Financials

  • Market Capitalization 233.08 M
  • Employee 142
  • Founded 2007
  • CEO Seth Lederman
  • Website www.tonixpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000LG8XM5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.07
Price to sales ratio
10.14

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3492
PRQR
ProQR Therapeutics N.V. - Ordinary Shares
2.29 USD-1.29%-2.14%+31.61%+2.23%241.28 M USD
3517
RNA
Atrium Therapeutics, Inc. - Common Stock
13.64 USD-2.43%+2.79%+20.39%-80.61%233.32 M USD
3529
NERV
Minerva Neurosciences, Inc - Common Stock
4.84 USD-5.65%+1.04%+17.48%+105.96%231.10 M USD
3535
GLSI
Greenwich LifeSciences, Inc. - Common stock
15.67 USD-16.34%-5.83%+20.82%+35.09%230.01 M USD

Frequently asked questions about Tonix Pharmaceuticals Holding Corp.

What is the Tonix Pharmaceuticals Holding Corp. stock price today?

The current price of Tonix Pharmaceuticals Holding Corp. (TNXP) is 13.59. Over the past 24 hours, the stock has changed by +0.22%. Follow the TNXP chart for real-time price dynamics.

What is the stock ticker of Tonix Pharmaceuticals Holding Corp.?

Tonix Pharmaceuticals Holding Corp. trades under the ticker TNXP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tonix Pharmaceuticals Holding Corp. stock going up?

TNXP has changed by +5.43% over the last week, +44.11% over the last month, and -9.46% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Tonix Pharmaceuticals Holding Corp.?

Tonix Pharmaceuticals Holding Corp. currently has a market capitalization of 233.08 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Tonix Pharmaceuticals Holding Corp. earnings last quarter?

Last quarter, Tonix Pharmaceuticals Holding Corp. reported earnings of -2.44 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Tonix Pharmaceuticals Holding Corp. revenue for the last quarter?

Tonix Pharmaceuticals Holding Corp. reported quarterly revenue of 13.54 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Tonix Pharmaceuticals Holding Corp. net income for the last quarter?

Tonix Pharmaceuticals Holding Corp. reported net income of -40.55 M for the last quarter. The previous quarter showed -40.19 M, which means net income changed by -0.89%.

How many employees does Tonix Pharmaceuticals Holding Corp. have?

As of the latest available data, Tonix Pharmaceuticals Holding Corp. has 142 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Tonix Pharmaceuticals Holding Corp. stock?

You can buy Tonix Pharmaceuticals Holding Corp. (TNXP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tonix Pharmaceuticals Holding Corp. stock?

Investing in Tonix Pharmaceuticals Holding Corp. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TNXP chart and related analysis on metatrader.com as part of your research.

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

News